Insider Selling: Nature’s Sunshine Products (NASDAQ:NATR) EVP Sells $200,476.32 in Stock

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) EVP Daniel Norman sold 9,713 shares of the business’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $20.64, for a total transaction of $200,476.32. Following the sale, the executive vice president directly owned 47,276 shares of the company’s stock, valued at approximately $975,776.64. The trade was a 17.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Nature’s Sunshine Products Price Performance

Shares of NATR stock opened at $19.79 on Friday. Nature’s Sunshine Products, Inc. has a 1 year low of $12.97 and a 1 year high of $28.14. The firm has a fifty day moving average price of $24.14 and a 200-day moving average price of $23.79. The company has a market cap of $347.91 million, a price-to-earnings ratio of 17.99 and a beta of 0.86.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $0.10. Nature’s Sunshine Products had a net margin of 4.06% and a return on equity of 14.67%. The firm had revenue of $122.89 million during the quarter, compared to the consensus estimate of $122.15 million.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on NATR shares. Canaccord Genuity Group set a $37.00 price objective on shares of Nature’s Sunshine Products in a research report on Friday, May 8th. DA Davidson reaffirmed a “buy” rating and issued a $33.00 target price on shares of Nature’s Sunshine Products in a report on Monday, May 11th. Finally, Weiss Ratings downgraded shares of Nature’s Sunshine Products from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, May 26th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, Nature’s Sunshine Products currently has an average rating of “Buy” and a consensus target price of $35.00.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. State of Alaska Department of Revenue bought a new position in Nature’s Sunshine Products in the 4th quarter worth $31,000. New York State Teachers Retirement System bought a new position in Nature’s Sunshine Products in the 1st quarter worth $37,000. Clearstead Advisors LLC boosted its holdings in Nature’s Sunshine Products by 16,025.0% in the 4th quarter. Clearstead Advisors LLC now owns 1,935 shares of the company’s stock worth $42,000 after buying an additional 1,923 shares during the period. McIlrath & Eck LLC bought a new position in Nature’s Sunshine Products in the 1st quarter worth $48,000. Finally, Raymond James Financial Inc. bought a new position in Nature’s Sunshine Products in the 2nd quarter worth $37,000. Institutional investors own 79.40% of the company’s stock.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.